Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03073330
Other study ID # 8550
Secondary ID
Status Recruiting
Phase N/A
First received August 11, 2016
Last updated March 2, 2017
Start date June 2016
Est. completion date June 2017

Study information

Verified date March 2017
Source Thomas Jefferson University
Contact Adeeb Khalifeh, MD
Email adeeb.khalifeh@jefferson.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Our study will assess if there is a difference in incidence of gestational diabetes using different screening approaches, either using a one-step approach with a 2 hour glucose tolerance test or using a two-step approach. Prior studies have proven similar incidences including a randomized controlled trial.


Description:

Gestational Diabetes is screened for in pregnancy by drinking a solution containing a certain amount of glucose and testing blood glucose level one hour after drinking it. If this value is above a certain cut-off (>135mg/dl), the patient is subjected to another test involving drinking a solution containing a higher amount of glucose and checking blood glucose while fasting, 1 hour after drinking the solution and 2 hours after drinking the solution. (Two step approach).

Cut off values will be: 3 hour>180 mg/dl, 2 hour > 155 mg/dl, 1hour >140 mg/dl, fasting >95mg/dl. Two abnormal values will meet the diagnosis of gestational diabetes.

In other parts of the United States, and most of the rest of the word, screening for gestational diabetes uses a one-step approach by drinking a solution containing 75g of glucose (As recommended by the American Diabetic Society, the Endocrine Society, WHO and the International Association of Diabetes and Pregnancy Study groups1-3). Blood glucose values are checked at fasting, one hour and two hours after solution drinking.

The diagnosis of gestational diabetes is based on one elevated values. (cut off: Fasting ≥92mg/dl, 1hour ≥180 mg/dl, 2 hours ≥153 mg/dl).

Our study will assess if there is a difference in incidence of gestational diabetes using these different screening approaches. Prior studies have proven similar incidences including a randomized controlled trial.


Recruitment information / eligibility

Status Recruiting
Enrollment 284
Est. completion date June 2017
Est. primary completion date March 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 16 Years to 50 Years
Eligibility Inclusion Criteria:

- 16-50 year of age

- Pregnant women (limits the participants to female gender)

Exclusion Criteria:

- Pregestational Diabetes Mellitus

- History of bariatric surgery

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
GDM screening with 75 g 2 hour GTT
Patients will be diagnosed with gestational diabetes if they have one abnormal value: Fasting = 92; 2 hour = 180 mg/dl;1 hour = 153 mg/dl.
GDM screening with two step approach
1 hour glucola with 50 g glucose load followed by 100 g glucose load if 1 hour glucola positive

Locations

Country Name City State
United States Thomas Jefferson University Hospital Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Thomas Jefferson University

Country where clinical trial is conducted

United States, 

References & Publications (1)

Southwick AM, Wang LX, Long SR, Lee YC. Activity of Sinorhizobium meliloti NodAB and NodH enzymes on thiochitooligosaccharides. J Bacteriol. 2002 Jul;184(14):4039-43. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of gestational diabetes diagnosed on each screening test of each arm. Gestational diabetes will be made based on one abnormal value. Fasting =126 mg/dl; 1 hour= 180 mg/dl and 2 hour = 153 mg/dl at the time of the screening
Secondary neonatal hyperbilirubinemia incidence of neonatal hyperbilirubinemia first 48 hours of life
Secondary mode of delivery incidence of cesarean delivery, spontaneous vaginal delivery, operative vaginal delivery, and induction of labor at time of delivery
Secondary gestational age at delivery gestational age at delivery at time of delivery
Secondary Anal sphincter injury Incidence of Anal sphincter injury at time of delivery
Secondary Shoulder dystocia incidence of shoulder dystocia, and birth trauma at time of delivery
Secondary Neonatal complications includes necrotizing enterocolitis, respiratory distress syndrome, intraventricular hemorrhage, hypoglycemia, jaundice, hyperbilirubinemia, perinatal death, admission to neonatal intensive care unit between birth and 28 days of age
Secondary Hypertensive disorders in pregnancy includes gestational hypertension, preeclampsia 6 months
Secondary Fetal growth restriction, large for gestational age and polyhydramnios Incidence of Fetal growth restriction,large for gestational age and polyhydramnios 6 months
Secondary Birth weight Mean of birth weight and incidence of macrosomia Time of delivery
Secondary Apgar score Apgar score at 1, 5 and 10 minutes after birth
See also
  Status Clinical Trial Phase
Recruiting NCT05081037 - Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS) N/A
Active, not recruiting NCT03249896 - Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes N/A
Terminated NCT03749889 - Low Carb vs Normal Carb in Pregnancy N/A
Completed NCT03859193 - Education Nutritional Video for Gestational Diabetics N/A
Recruiting NCT05037526 - Utility of Real Time Continuous Glucose Monitoring in the Care of Gestational Diabetes Versus Standard Care in Pregnancy Outcomes N/A
Completed NCT06178250 - Placenta, Fetal Liver, Sectional Ductus Venosus Volumes Examined by Three-dimensional Ultrasound in the Second Trimester N/A
Not yet recruiting NCT06310356 - Continuous Glucose Monitoring for Women With Gestational Diabetes N/A
Not yet recruiting NCT06445530 - Nutrition Optimization and Community Upliftment for Postpartum Recovery N/A
Recruiting NCT02590016 - Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial Phase 4
Not yet recruiting NCT00883259 - Metformin and Gestational Diabetes in High-risk Patients: a RCTs Phase 4
Withdrawn NCT01947699 - Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide Phase 4
Recruiting NCT03008824 - Micronutrients in Pregnancy as a Risk Factor for Diabetes and Effects on Mother and Baby N/A
Active, not recruiting NCT01340924 - Relationship Between Gestational Diabetes and Type 2 Diabetes
Completed NCT00534105 - Lipid Metabolism in Gestational Diabetes N/A
Recruiting NCT00371306 - Comparison of Glucovance to Insulin for Diabetes During Pregnancy N/A
Completed NCT03388723 - Intergenerational Programming of Diabesity in Offspring of Women With Gestational Diabetes Mellitus
Recruiting NCT04521712 - Postpartum Glycemia in Women at Risk For Persistent Hyperglycemia N/A
Enrolling by invitation NCT03307486 - Gestational Diabetes: a Cohort Study N/A
Active, not recruiting NCT03301792 - Group Versus Traditional Prenatal Care for Diabetes N/A
Enrolling by invitation NCT05603793 - YoUng Adolescents' behaViour, musculoskeletAl heAlth, Growth & Nutrition